387 related articles for article (PubMed ID: 25462575)
1. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
[TBL] [Abstract][Full Text] [Related]
2. Concomitant treatment with temozolomide enhances apoptotic cell death in glioma cells induced by photodynamic therapy with talaporfin sodium.
Miki Y; Akimoto J; Omata H; Moritake K; Hiranuma M; Hironaka C; Fujiwara Y; Beppu M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):556-64. PubMed ID: 25262961
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
Miki Y; Akimoto J; Moritake K; Hironaka C; Fujiwara Y
Lasers Med Sci; 2015 Aug; 30(6):1739-45. PubMed ID: 26109138
[TBL] [Abstract][Full Text] [Related]
5. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
7. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
Harvey EH; Webber J; Kessel D; Fromm D
Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells.
Miki Y; Akimoto J; Yokoyama S; Homma T; Tsutsumi M; Haraoka J; Hirano K; Beppu M
Biol Pharm Bull; 2013; 36(2):215-21. PubMed ID: 23196427
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.
Aggarwal N; Santiago AM; Kessel D; Sloane BF
Breast Cancer Res Treat; 2015 Nov; 154(2):251-62. PubMed ID: 26502410
[TBL] [Abstract][Full Text] [Related]
10. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Ferrario A; Kessel D; Gomer CJ
Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
[TBL] [Abstract][Full Text] [Related]
11. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
13. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Gomer CJ; Ferrario A
Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
[TBL] [Abstract][Full Text] [Related]
15. Role of p38MAPK in apoptosis and autophagy responses to photodynamic therapy with Chlorin e6.
Xue Q; Wang X; Wang P; Zhang K; Liu Q
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):84-91. PubMed ID: 25528442
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
18. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
19. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
